Advertisement
U.S. markets closed

Sunzen Biotech Berhad (0148.KL)

Kuala Lumpur - Kuala Lumpur Delayed Price. Currency in MYR
0.32000.0000 (0.00%)
At close: 04:08PM MYT
Currency in MYR

Valuation Measures4

Market Cap (intraday) 249.64M
Enterprise Value 229.65M
Trailing P/E 50.48
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.00
Price/Book (mrq)1.79
Enterprise Value/Revenue 2.68
Enterprise Value/EBITDA 20.23

Trading Information

Stock Price History

Beta (5Y Monthly) 1.75
52-Week Change 345.45%
S&P500 52-Week Change 339.39%
52 Week High 30.4000
52 Week Low 30.2150
50-Day Moving Average 30.3276
200-Day Moving Average 30.3271

Share Statistics

Avg Vol (3 month) 31.2M
Avg Vol (10 day) 31.13M
Shares Outstanding 5780.13M
Implied Shares Outstanding 6792.32M
Float 8287.8M
% Held by Insiders 155.95%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 08, 2017
Last Split Factor 23:2
Last Split Date 3Apr 29, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 6.43%
Operating Margin (ttm)5.21%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)95.13M
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA 13.16M
Net Income Avi to Common (ttm)6.13M
Diluted EPS (ttm)0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)27.65M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)7.66M
Total Debt/Equity (mrq)5.11%
Current Ratio (mrq)7.14
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)8.98M
Levered Free Cash Flow (ttm)N/A